Covidien Sales Reps' OT Suit Nixed By High Court GSK Ruling

Law360, New York (June 28, 2012, 1:17 PM EDT) -- Covidien Inc. on Wednesday escaped a putative class action from pharmaceutical sales representatives who allege the company misclassified them as exempt from overtime laws, following the U.S. Supreme Court’s decision in Michael Shane Christopher et al. v. Smithkline Beecham Corp.

In light of the Supreme Court’s June 18 decision, U.S. District Judge Curtis L. Collier lifted a stay in the case and granted Covidien’s motion for summary judgment, finding that Covidien sales representatives are not entitled to receive overtime pay.

In its 5-4 decision, the Supreme...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Burdine v. Covidien Inc.


Case Number

1:10-cv-00194

Court

Tennessee Eastern

Nature of Suit

Labor: Fair Standards

Judge

Curtis L Collier

Date Filed

July 19, 2010

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.